Edgar Filing: STREAMLINE HEALTH SOLUTIONS INC.

Streamline Health Solutions, Inc.

Date: January 26, 2012

/s/ Stephen H. Murdock

Stephen H. Murdock

Chief Financial Officer

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 24, 2012

Streamline Health Solutions, Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-28132

31-1455414

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

10200 Alliance Road, Suite 200, Cincinnati, OH 45242-4716

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (513) 794-7100

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01

Other Events.

At its meeting on January 24, 2012, the Board of Directors (“Board”) of Streamline Health Solutions, Inc. (the “Company”) appointed directors to the Company’s Board committees as set forth below:

Audit Committee

Edward J. VonderBrink, Chair

Richard C. Levy, M.D.

Jay D. Miller

Andrew L. Turner

Compensation Committee

Andrew L. Turner, Chair

Jay D. Miller

Edward J. VonderBrink

Nominating and Governance Committee

Richard C. Levy, M.D., Chair

Michael K. Kaplan

Jonathan R. Phillips

Strategy Committee

Michael K. Kaplan, Chair

Robert E. Watson

Jonathan R. Phillips

As Chairman of the Board of Directors, Mr. Phillips will participate as an observer to the Audit and Compensation Committees.

Pursuant to the Company’s bylaws, the Board has the power at any time to fill vacancies in, to change the membership of, and to discharge any committee.

The information in this Form 8-K shall not be deemed filed for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference.

Signatures

Pursuant to the requirements of the Securities Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.